The Eye Cancer Foundation (ECF) is pleased to announce funding to support retinoblastoma education fellowships for candidates from unserved and underserved countries. These fellowships may be from the ECF, Princess Margaret Cancer Center, and/or the International Council of Ophthalmology.
The following article by Dr. Finger was originally published on Retinal Physician. Find it here.
Benjamin Franklin once wrote, “an ounce of prevention is worth a pound of cure.”1 Although he was referring to fire prevention, this adage also applies to radiation maculopathy.
Over the years, I have relentlessly sought ways to decrease therapeutic radiation to the fovea and optic nerve. For example, in the 1980s, I studied adding intraocular microwave hyperthermia to lowered doses of plaque radiation therapy for the treatment of choroidal melanoma.2
However, it was not until the mid-1990s that I discovered a simple, low-risk opportunity to improve plaque radiation therapy.5–7 Compared to iodine-125, the use of lower-energy palladium-103 photons shifted the intraocular dose distribution.8 It increased the dose within the tumor, while decreasing irradiation of most normal ocular structures.9 Continue reading…